<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Possible modulatory effect of tadalafil and bergapten on experimentally induced cognitive impairment in mice</title>
  </titleInfo>
  <titleInfo type="alternative">
    <title>تأثير فاعلية التطبيع المحتمل لعقارى التادالافيل والبيرجابتين لاعتلال الادراك المستحدث تجريبيا فى الفئران</title>
  </titleInfo>
  <name type="personal">
    <namePart>Mohamed Ahmed Mahmoud Salem</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Nesrine Salah Eldine Elsayed</namePart>
    <role>
      <roleTerm type="text">Supervisor</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Suzan Mohamed Mansour</namePart>
    <role>
      <roleTerm type="text">Supervisor</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">theses</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">ua</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Cairo</placeTerm>
    </place>
    <publisher>Mohamed Ahmed Mahmoud Salem</publisher>
    <dateIssued>2021</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>139 P . :  charts , facsmilies ;  25cm</extent>
  </physicalDescription>
  <abstract>Sporadic Alzheimer{u2019}s disease (SAD) is a slowly progressive neurodegenerative disorder characterized by deposition of amyloid beta (AÝ) plaques, tau protein aggregation, impaired insulin signaling, and neuroinflammation. This study aimed to investigate the neuroprotective potential of tadalafil (TAD) and bergapten (BG) in SAD-induced cognitive impairment in mice. SAD was induced by a single intracerebroventricular injection of streptozotocin (STZ) (3 mg/kg). TAD or BG was administered intraperitoneally at doses of 20 and 25 mg/kg, respectively, 5 hours after STZ injection for 21 consecutive days. TAD and BG conceivably attenuated STZ-induced hippocampal insult, preserved neuronal integrity, and improved cognitive function in the Morris water maze and object recognition tests paralleled by reduced AÝ expression and phosphorylation of tau. Moreover, TAD and BG enhanced the protein expression of pAkt, pGSK-3Ý, beclin-1, and methylated protein phosphatase 2A (PP2A) and cyclin D1 gene expression and raised brain-derived neurotrophic factor immunoreactivity. In addition, both drugs boosted the hippocampal levels of cyclic guanosine monophosphate (cGMP), protein kinase G (PKG), WNT3A, and adenosine monophosphate-activated protein kinase coupled by reduced protein expression of Ý-catenin and mammalian target of rapamycin (mTOR). TAD and BG also halted neuroinflammation as evidenced by reduced IL-23 and IL-27 levels and NF-mB protein expression</abstract>
  <targetAudience authority="marctarget">specialized</targetAudience>
  <note type="statement of responsibility">Mohamed Ahmed Mahmoud Salem ; Supervised Nesrine Salah Eldine Elsayed , Suzan Mohamed Mansour</note>
  <note>Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Toxicology and Biochemistry</note>
  <note>Issued also as CD</note>
  <subject>
    <topic>Bergapten</topic>
  </subject>
  <subject>
    <topic>Sporadic Alzheimer{u2019}s disease</topic>
  </subject>
  <subject>
    <topic>Tadalafil </topic>
  </subject>
  <identifier type="uri">http://172.23.153.220/th.pdf</identifier>
  <location>
    <url>http://172.23.153.220/th.pdf</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">EG-GiCUC</recordContentSource>
    <recordCreationDate encoding="marc">220110</recordCreationDate>
    <recordChangeDate encoding="iso8601">20250223032911.0</recordChangeDate>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
